Vaccine News and Research

Latest Vaccine News and Research

New method for rapid screening large numbers of antigens

A team of Washington State University scientists has devised a method that could lead to the development of vaccines against some of the most troubling infectious diseases we face diseases that have so far been difficult or impossible to vaccinate against.

26 Mar 2008

Discovery about fertilization points way to possible malaria vaccine

International investigations of an organism that one UT Southwestern Medical Center researcher calls a “silly little green scum” have led to key insights into the basic mechanisms of reproduction.

26 Mar 2008

Scientists discover how salmonella becomes lethal for AIDS patients

Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea.

25 Mar 2008

Military to fight Dengue fever in Rio de Janeiro, Brazil

Since the beginning of the year across the state of Rio, 49 people have died from the potentially deadly fever, the vast majority of victims have been in the city itself, with hospitals struggling to cope.

24 Mar 2008

Typhoid no longer an enemy of the past as study highlights risk for travellers to indian sub-continent

UK travellers visiting friends and relatives on the Indian sub-continent are carrying an unnecessary burden of typhoid and paratyphoid (also called enteric fevers), according to researchers at the Health Protection Agency.

24 Mar 2008

The body's fight with cervical cancer

The virus responsible for most cases of cervical cancer has a serious weakness which may provide hope for new treatments for the disease.

24 Mar 2008

PharmAthene signs agreement to acquire biodefense vaccines business from Avecia

PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.

24 Mar 2008

Infection with a mutated HIV strain results in better survival

Persons infected with a mutated HIV strain, transmitted from those who have the genetic advantages to control the virus, results in improved survival according to a recent study by South African researchers.

24 Mar 2008

Call to step up the fight against tuberculosis

In honor of World TB Day 2008 (March 24), the Infectious Diseases Society of America (IDSA) and the HIVMA Medicine Association (HIVMA) urged U.S. policymakers to step up the fight against tuberculosis by committing substantial resources against the disease both at home and abroad.

24 Mar 2008

WHO warns Aussies to prepare for deadly flu

The World Health Organisation (WHO) is warning Australians to prepare for a potentially deadly flu season.

23 Mar 2008

Skin patch gives bird flu vaccine a big boost

Researchers testing an experimental skin patch designed to boost an H5N1 vaccine say preliminary results have been promising.

21 Mar 2008

New understanding of Norwalk virus

Using the Canadian Light Source synchrotron, an international team led by University of Calgary researcher Ken Ng has determined the detailed structure of the enzyme the Norwalk virus uses to make copies of its genetic code in order to replicate itself.

20 Mar 2008

Single dose of doxycycline protects from Lyme disease

Lyme disease is the blight of countryside users but it may be prevented with a single injection, according to research published in the Journal of Medical Microbiology.

20 Mar 2008

UN gives stark warning about bird flu threat from Indonesia

Any danger that the world has become bored or complacent regarding the threat of bird flu will be dispelled by a stark warning from the United Nations' Food and Agriculture Organization (FAO).

19 Mar 2008

Pneumococcal disease rates down since approval of a vaccine in 2000

Since the approval of a vaccine against pneumococcal bacteria for young children in 2000, rates of invasive pneumococcal disease (IPD) are down significantly in all age groups, while rates of IPD caused by non-vaccine strains are modestly on the rise.

19 Mar 2008

New understanding of rare immune disorder called Job's syndrome

Scientists have made another major breakthrough--the second in the past year--in understanding a rare immune disorder called Job's syndrome.

18 Mar 2008

NanoBio successfully completes phase 2b study in Herpes labialis

NanoBio Corporation reported top-level findings from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores).

18 Mar 2008

A new inhaled TB vaccine

A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide.

17 Mar 2008

Modified virus vaccine shows promise in mouse model of breast cancer

Researchers have shown that vaccinating mice with a modified form of a virus containing proteins from breast cancer cells can kill large breast cancer tumors and tumors that have spread to the lungs.

17 Mar 2008

SWHR statement on CDC report on young women and STDs

Society for Women's Health Research President and CEO Phyllis Greenberger, M.S.W., issued the following statement in response to a Centers for Disease Control and Prevention study released yesterday, which found that one in four females aged 14-19 has a sexually transmitted disease:

14 Mar 2008